Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 6 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 4 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via Yahoo News· 6 days agoIt can also just... feel nice. Boost blood flow to scalp You may have heard that hot oil treatments...
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 2 days agoSiliq (brodalumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis in adults...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 2 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 4 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 6 days agoA decision on approval is expected in the fourth quarter of 2024.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 6 days agoThe Law Offices of Frank R. Cruz reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ventyx ...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 20 hours agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 4 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.